Sting Relief
FDA Label NDC 71622-002

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Mcl Enterprises for the product Sting Relief (NDC 71622-002). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, purpose, use:, warnings:, do not use:, stop use:, keep out of reach of children., directions:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Active Ingredient

Benzocaine, 6% w/w

Isopropyl Alcohol, 60% v/v

Purpose

Topical Anesthetic

Antiseptic

Use:

For temporary relief of pain and itching associated with minor insect stings and bites.

Warnings:

  • Flammable, keep away from fire or flame

Do Not Use:

  • in the eyes
  • if contact occurs, flush with water

Stop Use:

  • if irritation and redness develop. If condition persists consult your health care practitioner.

Keep Out Of Reach Of Children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions:

For adults and children 2 years of older, apply to affected area 3 to 4 times daily. For children under 2 years of age, consult a physician before use.

Inactive Ingredient:

Purified Water

Package Labeling:

Label2 (Label2)

Label2 (Label2)

* Please review the disclaimer below.